154 related articles for article (PubMed ID: 15989770)
1. Severe vulgaris psoriatic patients with acute myelogenous leukaemia and resolution after allogeneic bone marrow transplantation/peripheral blood stem cell transplantation.
He YL; Lu XJ; Qiu JY; Zhu TJ
Chin Med J (Engl); 2005 May; 118(10):861-5. PubMed ID: 15989770
[No Abstract] [Full Text] [Related]
2. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
3. [Transient chromosomal abnormalities following autologous peripheral blood stem cell transplantation for acute myelogenous leukemia].
Usuki K; Nakasone H; Taoka K; Kida M; Iki S; Urabe A
Rinsho Ketsueki; 2007 Aug; 48(8):618-23. PubMed ID: 17867297
[TBL] [Abstract][Full Text] [Related]
4. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia.
Yin JA; Jowitt SN
Bone Marrow Transplant; 1992 Jan; 9(1):31-3. PubMed ID: 1543947
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
[TBL] [Abstract][Full Text] [Related]
7. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
[TBL] [Abstract][Full Text] [Related]
8. Reticulated platelets as a marker of platelet recovery after allogeneic stem cell transplantation.
Michur H; Maślanka K; Szczepiński A; Mariańska B
Int J Lab Hematol; 2008 Dec; 30(6):519-25. PubMed ID: 18983304
[TBL] [Abstract][Full Text] [Related]
9. Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia.
Nakaseko C; Sakaida E; Ohwada C; Ozawa S; Takeuchi M; Shimizu N; Cho R; Yokota A; Saito Y; Nishimura M
Ann Hematol; 2007 Jan; 86(1):67-9. PubMed ID: 17021838
[No Abstract] [Full Text] [Related]
10. Marrow aplasia developing 13 years after HLA-identical sibling allogeneic transplantation for chronic myeloid leukaemia: successful treatment with antithymocyte globulin and peripheral blood stem cell infusion from the original donor.
O'Donghaile D; Hayden PJ; McCarron SL; Doyle EM; Lawler M; Browne PV; Conneally E; Vandenberghe E; McCann SR
Eur J Haematol; 2006 Mar; 76(3):258-60. PubMed ID: 16451399
[TBL] [Abstract][Full Text] [Related]
11. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
[TBL] [Abstract][Full Text] [Related]
12. Long-term remissions in patients with myelodysplastic syndrome and secondary acute myelogenous leukemia undergoing allogeneic transplantation following a reduced intensity conditioning regimen of 550 cGy total body irradiation and cyclophosphamide.
Hallemeier CL; Girgis MD; Blum WG; Brown RA; Khoury HJ; Devine SM; Vij R; Lin HS; DiPersio JF; Adkins DR
Biol Blood Marrow Transplant; 2006 Jul; 12(7):749-57. PubMed ID: 16785064
[TBL] [Abstract][Full Text] [Related]
13. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
Gorin NC; Labopin M; Frassoni F; Milpied N; Attal M; Blaise D; Meloni G; Iori AP; Michallet M; Willemze R; Deconninck E; Harousseau JL; Polge E; Rocha V
J Clin Oncol; 2008 Jul; 26(19):3183-8. PubMed ID: 18506024
[TBL] [Abstract][Full Text] [Related]
14. [Second nonmyeloablative allogeneic peripheral blood stem cell transplantation with more immunosuppressive conditioning regimen for the late graft failure of the patient with acute myeloid leukemia].
Tachikawa Y; Abe Y; Choi I; Ohtsuka R; Nagasawa E; Shibata K; Nishimura J; Nawata H; Muta K
Fukuoka Igaku Zasshi; 2005 Nov; 96(11):378-82. PubMed ID: 16502857
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
Rowe JM
Best Pract Res Clin Haematol; 2008 Sep; 21(3):485-502. PubMed ID: 18790451
[TBL] [Abstract][Full Text] [Related]
16. Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients.
Pérez A; González-Vicent M; Ramirez M; Sevilla J; Madero L; Díaz MA
Br J Haematol; 2008 Feb; 140(3):340-3. PubMed ID: 18053071
[TBL] [Abstract][Full Text] [Related]
17. Outcome after allogeneic bone marrow transplantation in cytogenetic high-risk myelodysplastic syndromes and acute myeloid leukemia.
Della Porta MG; Malcovati L
Haematologica; 2005 Oct; 90(10):1298C. PubMed ID: 16219554
[No Abstract] [Full Text] [Related]
18. Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and/or 7 abnormalities.
van der Straaten HM; van Biezen A; Brand R; Schattenberg AV; Egeler RM; Barge RM; Cornelissen JJ; Schouten HC; Ossenkoppele GJ; Verdonck LF;
Haematologica; 2005 Oct; 90(10):1339-45. PubMed ID: 16219570
[TBL] [Abstract][Full Text] [Related]
19. Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia.
Kim HJ; Min WS; Eom KS; Cho BS; Kim SY; Bok JN; Kim KS; Min CK; Lee S; Cho SG; Kim DW; Lee JW; Kim CC
Bone Marrow Transplant; 2007 Dec; 40(11):1069-74. PubMed ID: 17922041
[TBL] [Abstract][Full Text] [Related]
20. Autologous stem cell transplantation in myelodysplastic syndromes.
de Witte T; Suciu S; Brand R; Muus P; Kröger N
Semin Hematol; 2007 Oct; 44(4):274-7. PubMed ID: 17961727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
